NHS reimburses Roche's Hemlibra in new group of haemophilia ...

NHS England has agreed to reimburse Roche’s Hemlibra (emicizumab) in a new group of patients with haemophilia A, widening access to the potentially life-saving drug.

Lilly faces biosimilar rivals to osteoporosis drug Forsteo i...

FDA says no to Sarepta's golodirsen, blocking bid to expand ...

AbbVie prices Rinvoq close to Humira after arthritis approva...

Scotland's cost regulator rejects Vertex cystic fibrosis dru...

Scotland’s cost-effectiveness body has rejected regular NHS funding for Vertex’s cystic fibrosis drugs Orkambi and Symkevi because of concerns about whether their high costs justify uncerta

US senators blast Novartis for Zolgensma data falsification

US politicians have urged the FDA to come down hard on Novartis for failing to disclose manipulated data used in the approval of its $2.1 million spinal muscular atrophy (SMA) gene therapy Zolge